Lineage Therapeutics announces US launch of generic epinephrine auto-injector

Lineage Therapeutics Inc. has announced the US launch of its generic epinephrine injection, USP auto-injector, the authorized generic of Adrenaclick® by Amedra Pharmaceuticals LLC, for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The product is available as a two-pack carton in both 0.15 mg and 0.30 mg strengths. 

Lineage's epinephrine auto-injector is the only generically priced epinephrine auto-injector currently available. This authorized generic epinephrine injection, USP auto-injector, is being reintroduced to the market as it was previously marketed under prior ownership.

According to Dr. F. Estelle R. Simons, Professor, Department of Pediatrics & Child Health at the University of Manitoba, "There is a long-standing need for an inexpensive epinephrine auto-injector."

Epinephrine Auto-Injectors, 0.15 mg and 0.30 mg, had U.S. sales of approximately $758 million for the 12 months ending April 30, 2013, according to IMS Health.